Xuelai Luo
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Extracellular vesicles in disease
- Circular RNAs in diseases
- Cancer-related gene regulation
- RNA modifications and cancer
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 11
- Epigenetics and DNA Methylation 10
- Chromatin Remodeling and Cancer 6
- Cancer-related gene regulation 5
- Oncology 14
- Cancer-related Molecular Pathways 6
- Co-authors
- Junbo Hu (46 shared papers)Guihua Wang (34 shared papers)Fuqing Hu (17 shared papers)Jingqin Lan (11 shared papers)Yongdong Feng (15 shared papers)Zhenlin Hou (7 shared papers)Da Song (9 shared papers)Xi Yang (10 shared papers)
- Journals
- Cell Death and Disease (7 papers)Oncogene (3 papers)Oncotarget (3 papers)Molecular Cancer Therapeutics (3 papers)Experimental Cell Research (3 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Xuelai Luo
60 papers receiving 2.3k citations
Xuelai Luo's Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 652
- Molecular Biology 1.4k
- Immunology 351
- Geriatrics and Gerontology 46
- Oncology 346
Countries citing papers authored by Xuelai Luo
This map shows the geographic impact of Xuelai Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuelai Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuelai Luo more than expected).
Fields of papers citing papers by Xuelai Luo
This network shows the impact of papers produced by Xuelai Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuelai Luo. The network helps show where Xuelai Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuelai Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer Hit paper breakdown → | 2018 | 528 |
| 2 | 2021 | 177 | |
| 3 | 2011 | 133 | |
| 4 | 2018 | 83 | |
| 5 | 2020 | 76 | |
| 6 | 2018 | 69 | |
| 7 | 2015 | 55 | |
| 8 | 2020 | 54 | |
| 9 | 2014 | 53 | |
| 10 | 2012 | 53 | |
| 11 | 2017 | 50 | |
| 12 | 2021 | 47 | |
| 13 | 2020 | 43 | |
| 14 | 2023 | 43 | |
| 15 | 2018 | 42 | |
| 16 | Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis Hit paper breakdown → | 2025 | 41 |
| 17 | 2020 | 41 | |
| 18 | 2018 | 40 | |
| 19 | 2023 | 39 | |
| 20 | 2008 | 39 |
About Xuelai Luo
Xuelai Luo is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Pulmonary and Respiratory Medicine, having authored 62 papers that have together received 2.4k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (11 papers), Epigenetics and DNA Methylation (10 papers), Cancer-related Molecular Pathways (6 papers), Chromatin Remodeling and Cancer (6 papers), Cancer-related gene regulation (5 papers), MicroRNA in disease regulation (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Cancer Research (652 citations), Molecular Biology (1.4k citations), Immunology (351 citations), Geriatrics and Gerontology (46 citations) and Oncology (346 citations). Xuelai Luo has collaborated with scholars based in China, United States and India. Frequent co-authors include Junbo Hu, Guihua Wang, Fuqing Hu, Jingqin Lan, Yongdong Feng, Zhenlin Hou, Da Song, Xi Yang, Feng Xu and Xianglin Yuan. Their work appears in journals such as Cell Death and Disease, Oncogene, Oncotarget, Molecular Cancer Therapeutics and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.